Lpl Financial LLC Cyma Bay Therapeutics, Inc. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $350,646 - $679,360	-27,763 Reduced 22.5%	95,601 $2.26 Million
Q3 2023 Nov 13, 2023	SELL	$10.86 - $17.62 $89,117 - $144,589	-8,206 Reduced 6.24%	123,364 $1.84 Million
Q2 2023 Jul 31, 2023	BUY	$7.47 - $10.95 $95,175 - $139,513	12,741 Added 10.72%	131,570 $1.44 Million
Q1 2023 May 10, 2023	BUY	$5.88 - $9.59 $15,382 - $25,087	2,616 Added 2.25%	118,829 $1.04 Million
Q4 2022 Feb 07, 2023	BUY	$3.22 - $6.27 $66,393 - $129,281	20,619 Added 21.57%	116,213 $728,000
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $123,450 - $189,409	44,567 Added 87.34%	95,594 $335,000
Q2 2022 Aug 12, 2022	BUY	$1.72 - $3.39 $1,986 - $3,915	1,155 Added 2.32%	51,027 $151,000
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $13,825 - $18,167	-4,991 Reduced 9.1%	49,872 $155,000
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $68,362 - $97,358	21,165 Added 62.81%	54,863 $185,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $52,050 - $66,300	-15,000 Reduced 30.8%	33,698 $123,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $4.92 $59,356 - $74,119	15,065 Added 44.79%	48,698 $212,000
Q1 2021 May 14, 2021	BUY	$4.23 - $6.55 $60,700 - $93,992	14,350 Added 74.42%	33,633 $153,000
Q4 2020 Feb 12, 2021	SELL	$5.73 - $9.03 $435 - $686	-76 Reduced 0.39%	19,283 $111,000
Q3 2020 Nov 09, 2020	BUY	$3.32 - $7.24 $28,996 - $63,234	8,734 Added 82.2%	19,359 $140,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $4.25 $14,981 - $45,156	10,625 New	10,625 $37,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $20,267 - $90,367	-15,239 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.12 - $7.21 $1,658 - $2,336	324 Added 2.17%	15,239 $78,000
Q2 2019 Aug 09, 2019	SELL	$6.05 - $13.66 $1,954 - $4,412	-323 Reduced 2.12%	14,915 $107,000
Q1 2019 May 08, 2019	SELL	$8.16 - $13.42 $75,806 - $124,671	-9,290 Reduced 37.88%	15,238 $202,000
Q4 2018 Feb 07, 2019	SELL	$6.54 - $11.74 $5,846 - $10,495	-894 Reduced 3.52%	24,528 $193,000
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $276,591 - $369,127	25,422 New	25,422 $282,000
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $106,600 - $143,800	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $90,000 - $151,600	10,000 New	10,000 $130,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account